Form 4: Dentsply Sirona Director Jonathan Mazelsky Reports Acquisition of Stock and Phantom Stock

Sentiment:

SEC Form 4 Filing


Director Jonathan Mazelsky reports acquisition of common stock and phantom stock through dividend accruals.

Summary

  • On April 11, 2025, Jonathan Jay Mazelsky, a director of Dentsply Sirona Inc. [XRAY], reported changes in beneficial ownership.
  • Mazelsky acquired 147.727 shares of common stock through dividend accruals on restricted stock units (RSUs).
  • He also acquired 74.8693 shares of phantom stock as a result of accrued dividends.
  • Following these transactions, Mazelsky beneficially owns 13,932.453 shares of common stock directly and 7,597.724 shares of phantom stock directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company through dividend reinvestment, which can be seen as a sign of confidence.

Positives

  • The acquisition of shares through dividend accruals indicates a continued investment in the company by the director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company through dividend reinvestment.

Stakeholder Impact

  • The report provides transparency to shareholders regarding the director's holdings and transactions.

Key Dates

DateDescription
04/11/2025Date of transaction: Acquisition of common stock and phantom stock.
04/15/2025Date of report filing.

Keywords

Form 4, Dentsply Sirona, XRAY, Jonathan Mazelsky, Beneficial Ownership, Common Stock, Phantom Stock, Dividends, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.